IMMUNOQURE AG
ImmunoQure AG rare natural antibodies derived from patients for patients. ImmunoQure AG is a young biotech company spearheading the research and development of human-derived antibodies (HD-MABs) for the treatment of human diseases. Through our unique access to rare patient populations, we are able to identify patients harboring naturally optimized antibodies against key drug targets that are involved in preventing a number of human diseases.
IMMUNOQURE AG
Industry:
Biotechnology Health Care Medical
Address:
Martinsried, Bayern, Germany
Country:
Germany
Website Url:
http://www.immunoqure.de
Status:
Active
Contact:
+49089416141353
Email Addresses:
[email protected]
Technology used in webpage:
SPF
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Inatherys
Inatherys is a biotechnology company developping monoclonal antibodies for the treatment of cancers and inflammatory diseases.
Marinomed
Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.
Pepsyn
Pepsyn is a biotechnology company, develops and markets milk-derived peptides for cosmetic.
Official Site Inspections
http://www.immunoqure.de
- Host name: ispconf05.rhein-it.de
- IP address: 80.252.111.87
- Location: Hamburg Germany
- Latitude: 53.5512
- Longitude: 9.9662
- Timezone: Europe/Berlin
- Postal: 20359
More informations about "ImmunoQure AG"
ImmunoQure AG - Crunchbase Company Profile & Funding
ImmunoQure AG rare natural antibodies derived from patients for patients. ImmunoQure AG is a young biotech company spearheading the research and development of human-derived …See details»
ImmunoQure AG - Martinsried, Germany - bionity.com
ImmunoQure AG is a young biotech company spearheading the research and development of human-derived antibodies (HD-MABs) for the treatment of human diseases. Through our …See details»
immunoqure.com
Immunoqure.comSee details»
ImmunoQure AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ImmunoQure AG of Düsseldorf, Nordrhein-Westfalen. Get the latest business insights from Dun & Bradstreet.See details»
ImmunoQure AG, Düsseldorf | Firmenauskunft - Creditreform
Firmenauskunft für ImmunoQure AG Gegenstand des Unternehmens Entwicklung von Antikörpern und antikörperbasierten Therapeutika für die Behandlung von humanen …See details»
ImmunoQure 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for ImmunoQure. Use the PitchBook Platform to explore the full profile.See details»
ImmunoQure AG - life-sciences-europe.com
ImmunoQure AG is a German biotechnology company based in Düsseldorf. Founded in 2011, by a consortium of scientists, biotech entrepreneurs, and APECED/APS1 patients, ImmunoQure …See details»
ImmunoQure AG - VentureRadar
ImmunoQure AG is a young biotech company spearheading the research & development of human-derived autoantibodies for the treatment of human diseases. Through our unique …See details»
ImmunoQure AG, Düsseldorf - North Data
ImmunoQure AG, Düsseldorf, Amtsgericht München HRB 192992: Patente, Netzwerk, WirtschaftsinfosSee details»
ImmunoQure AG - Implisense
Feb 13, 2025 Entdecken Sie die ImmunoQure AG auf Implisense, dem B2B-Portal für Firmeninformationen. Profil, Kontaktdaten, News - alles auf einen Blick!See details»
ImmunoQure AG - BioCentury Company Profiles - BCIQ
ImmunoQure AG - BioCentury Company Profiles for the biopharma industrySee details»
ImmunoQure AG, Dusseldorf, Germany - North Data
ImmunoQure AG, Dusseldorf, Germany, District Court of Munich HRB 192992: Patents, Network, Financial informationSee details»
ImmunoQure Research AG - Zürich, Switzerland - bionity.com
ImmunoQure AG is a young biotech company focused on generating novel antibody-based therapeutics for the treatment of inflammation and autoimmune diseases.See details»
ImmunoQure | Biotechnology | The Pharmaletter | The Pharmaletter
Immunoqure is a German biotech company that claims to be spearheading the development of human-derived antibodies.See details»
ImmunoQure And Memo Therapeutics Collaborate To Biobank …
Nov 7, 2019 ImmunoQure AG, a biotechnology company focused on the development of autoantibodies as therapeutics to treat human diseases and Memo Therapeutics AG, a …See details»
immunoqure.de
Immunoqure.deSee details»
Research programme: autoantibody therapeutics - ImmunoQure AG
Human derived autoantibody therapeutics are being developed by ImmunoQure AG, for the treatment of autoimmune disorders. The company is focussed on theSee details»
Strategic Partnership for the Development of an Interferon-alpha …
Feb 14, 2018 ImmunoQure, a biotech company focused on the research and development of human autoantibodies as therapeutics for the treatment of common human diseases and the …See details»
IQ-004 - Drug Targets, Indications, Patents - Synapse - Patsnap
IQ-004: a IFNα2 modulators Drug, Initially developed by Immunoqure AG, Now, its global highest R&D status is Preclinical, Mechanism: IFNα2 modulators (Interferon alpha-2 modulators), …See details»
ImmunoQure AG and Servier Enter into Strategic Partnership for …
Feb 14, 2018 ImmunoQure, a biotech company focused on the research and development of human autoantibodies as therapeutics for the treatment of common human diseases and the …See details»